Cancer Immunotherapy
Harnessing the immune system to fight cancer through checkpoint inhibitors, CAR-T therapies, and adoptive cell therapies.
Speaker profile
Conference homeSessions
A curated scientific program featuring parallel sessions across cancer immunotherapy, precision oncology, cancer genomics, and clinical research. The agenda includes keynote lectures, expert discussions, poster presentations, and interactive workshops designed to showcase breakthroughs and advance patient care.
The conference is organized around thematic tracks representing the main focus areas in cancer research and oncology. These tracks encourage participants to explore their specialization in depth while fostering cross-disciplinary collaboration.
Harnessing the immune system to fight cancer through checkpoint inhibitors, CAR-T therapies, and adoptive cell therapies.
Personalizing cancer treatment using molecular profiling, genomic data, and targeted therapeutic strategies.
Exploring cancer-stromal interactions, immune evasion mechanisms, and the ecosystem driving tumor progression.
Mapping the genomic landscape of malignancies to uncover drivers, resistance mechanisms, and therapeutic targets.
Advanced radiotherapy techniques, stereotactic approaches, and radiobiology for precision tumor control.
Leukemias, lymphomas, and myelomas: disease biology, diagnostics, and emerging therapeutic innovations.
Machine learning applications for early detection, pathology automation, and treatment response prediction.
Novel therapeutics, antibody-drug conjugates, clinical trial design, and regulatory pathways in cancer treatment.
Topics cover current and emerging research in cancer science, clinical oncology, and translational research—from laboratory discovery to patient care.
Program sessions include keynotes, oral presentations, poster sessions, and workshops fostering knowledge exchange and collaboration among cancer specialists.
Vision-defining talks from world-leading oncologists and cancer researchers, framing major themes and breakthroughs for the full audience.
Peer-reviewed cancer research presented as focused talks within parallel tracks and specialty sessions.
Dedicated gallery hours with authors present for in-depth discussion and structured networking.
Multi-stakeholder debates on clinical evidence, research gaps, and implementation in precision oncology.
Interactive small-group sessions focused on emerging cancer therapeutics, diagnostic tools, and clinical methods.
Mentored presentations and rapid-fire talks showcasing early-career oncology investigators and promising research.
Visit CVIC 2027 in San Diego, USA and discover the latest cancer research breakthroughs, connect with leading oncology experts, and collaborate with peers over two transformative days.